{
  "docId": "019dd923-5ca1-7489-b639-45501f4b359b",
  "docSlug": "158df8627a0b9aca",
  "documentTitle": "Opioid Conflicts Majority Staff Report",
  "authorId": "McKinsey",
  "authorName": "U.S. House Committee on Oversight and Reform",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.773,
  "pageNumber": 45,
  "pageCount": 53,
  "prevPage": 44,
  "nextPage": 46,
  "slideType": "appendix_disclosure",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "This slide appears to be a page from a formal report or legal document, containing narrative text and footnotes.",
  "elementsJson": [
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b639-45501f4b359b/45",
  "deckHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b#slide-45",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Thomas Latkovic, a senior partner, warned: 'This whole opioids thing is super sensitive with PMP [pharmaceutical and medical products] practice.'",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-cdec-74db-b49e-32e18394d16a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.76,
        "x": 0.12,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "Mr. Ghatak also suggested adding language to the Secretary Azar memo that acknowledged the value of the opioids his clients manufactured, noting, “we don’t mention that opioids do serve an important societal benefit, especially to chronic patients in severe pain.” He continued, “its [sic] just important to mention that side of the equation for balance.”216",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2d0138da-85d6-48f6-bb26-b0f5e2bf7aa1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.03,
        "x": 0.48,
        "y": 0.93
      },
      "kind": "paragraph",
      "text": "45",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7ec329e5-d693-4a35-ac08-fc3668538ee1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.76,
        "x": 0.12,
        "y": 0.47
      },
      "kind": "paragraph",
      "text": "That same day, Mr. Latkovic received a draft of the memo incorporating Mr. Ghatak’s suggestions.219 Mr. Latkovic pushed back on many of Mr. Ghatak’s recommendations, including Mr. Ghatak’s assertion that opioids provide a benefit to patients in pain. He wrote that “mentioning that opioids helps people in pain is actually a debatable point,” and noted that some policy actions to address the opioid crisis were “bad for Arnie’s client.”220",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cbf065b5-be52-400f-a39a-1327cfd8bca3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.76,
        "x": 0.12,
        "y": 0.11
      },
      "kind": "paragraph",
      "text": "Mr. Ghatak's recommendation in the 2018 Secretary Azar transition memo to limit HHS reimbursements to ADF opioids appeared consistent with long-standing advice McKinsey provided to Purdue on how to limit generic competition to its opioid drugs.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d8e13eb8-7ca5-4b5c-a08b-697590d2a092",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.76,
        "x": 0.12,
        "y": 0.27
      },
      "kind": "paragraph",
      "text": "Some McKinsey partners expressed concern about Mr. Ghatak offering feedback on the Secretary Azar memo. Thomas Latkovic, a senior partner who works with non-profit and government clients, told other McKinsey consultants on a separate email chain that he did not believe soliciting Mr. Ghatak’s input was a “fair request or a good idea,” and warned: “This whole opioids thing is super sensitive with PMP [pharmaceutical and medical products] practice.” Mr. Latkovic relayed that Mr. Ghatak had previously told him that “the word ‘epidemic’ and/or ‘crisis’ are hyperbolic.” Mr. Latkovic later reiterated, “I’m trying to highlight the hornet’s nest you are entering.”217 Another consultant on the chain responded, “Yeah. Will become CSRC [Client Services Risk Committee] issue,” referring to an internal committee within McKinsey that helps manage the firm’s business risks.218",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f1b9d771-8203-4296-8da7-108864f3e12c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "I'm trying to highlight the hornet's nest you are entering. — Thomas Latkovic",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd951-cdec-74db-b49e-3524c5c047b2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.35,
        "x": 0.12,
        "y": 0.8
      },
      "kind": "source-note",
      "text": "216 MCK-HCOR-0179910, Page 3 (emphasis added).\n217 MCK-HCOR-0261294.\n218 Id.\n219 MCK-HCOR-0261196.\n220 Id. (emphasis added).",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f257694a-34aa-47f8-ad7d-3951fd39571f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 53,
      "from": 29,
      "beatId": "1170eac2-9202-4b41-a53c-edbd934ded10",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "The document concludes with implications of McKinsey's actions and potential next steps for regulatory action.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 53,
      "from": 1,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "ee9686db-f8b5-4bc9-bf6e-2d29966ee033",
      "evidence": "The document implies the cost of inaction through its presentation of McKinsey's conflicts of interest and their potential impact on the opioid epidemic.",
      "position": 0,
      "objective": "What is the cost of inaction in addressing McKinsey's conflicts of interest?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}